These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11354296)

  • 1. Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome.
    Stegmayr BG
    Ther Apher; 2001 Apr; 5(2):123-7. PubMed ID: 11354296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apheresis in patients with severe sepsis and multi organ dysfunction syndrome.
    Stegmayr B
    Transfus Apher Sci; 2008 Jun; 38(3):203-8. PubMed ID: 18492616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome.
    Stegmayr B
    Clin Chem Lab Med; 1999 Mar; 37(3):327-32. PubMed ID: 10353479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a future for adsorption techniques in sepsis?
    Stegmayr BG
    Blood Purif; 2000; 18(2):149-55. PubMed ID: 10838475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange in severe sepsis or septic shock.
    Kes P
    Acta Med Croatica; 1998; 52(2):127-32. PubMed ID: 9682501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apheresis in patients with sepsis: A multicenter retrospective study.
    Aydin K; Korkmaz S; Erkurt MA; Sarici A; Ekinci O; Baysal NA; Berber I; Dogan A; Dal MS; Giden AO; Ulas T; Kuku I; Ozatli D; Eser B; Altuntas F
    Transfus Apher Sci; 2021 Oct; 60(5):103239. PubMed ID: 34412948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis in severe sepsis or septic shock.
    Stegmayr BG
    Blood Purif; 1996; 14(1):94-101. PubMed ID: 8718572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septic shock with multiorgan failure: from conventional apheresis to adsorption therapies.
    Stegmayr B; Abdel-Rahman EM; Balogun RA
    Semin Dial; 2012; 25(2):171-5. PubMed ID: 22329732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Benefits of Therapeutic Plasma Exchange in Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.
    Lee OPE; Kanesan N; Leow EH; Sultana R; Chor YK; Gan CS; Lee JH
    J Intensive Care Med; 2023 Jul; 38(7):598-611. PubMed ID: 37097910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patients with sepsis].
    Oppert M
    Med Klin Intensivmed Notfmed; 2016 May; 111(4):290-4. PubMed ID: 27160262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.
    Stegmayr BG; Banga R; Berggren L; Norda R; Rydvall A; Vikerfors T
    Crit Care Med; 2003 Jun; 31(6):1730-6. PubMed ID: 12794412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining continuous endotoxin apheresis and continuous hemodiafiltration in the treatment of patients with septic multiple organ dysfunction syndrome.
    Yonekawa C; Nakae H; Tajimi K; Asanuma Y
    Ther Apher Dial; 2006 Feb; 10(1):19-24. PubMed ID: 16556132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of superantigens and complex host responses in severe sepsis may need a broad therapeutic approach.
    Stegmayr BG
    Ther Apher; 2001 Apr; 5(2):111-4. PubMed ID: 11354294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There a Place for Apheresis in Patients with Severe Sepsis or Multi Organ Dysfunction Syndrome?
    Stegmayr BG
    Turk J Haematol; 2000 Mar; 17(1):5-11. PubMed ID: 27265757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sepsis. II. Complications and treatment of sepsis].
    Makovický P; Mokán M; Vladár L; Vrlík M
    Cas Lek Cesk; 1996 Oct; 135(19):614-6. PubMed ID: 8998803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column.
    Tani T; Hanasawa K; Endo Y; Yoshioka T; Kodama M; Kaneko M; Uchiyama Y; Akizawa T; Takahasi K; Sugai K
    Artif Organs; 1998 Dec; 22(12):1038-44. PubMed ID: 9876096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange in patients with septic shock including acute renal failure.
    Stegmayr BG
    Blood Purif; 1996; 14(1):102-8. PubMed ID: 8718573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early use of polymyxin B in sepsis].
    Nalesso F
    G Ital Nefrol; 2012; 29 Suppl 54():S64-6. PubMed ID: 22388833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.